Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/23/1991 | EP0452926A2 5-aryl-4-alkyl-3H-1,2,4-triazole-3-thiones useful as memory enhancers |
10/23/1991 | EP0452908A2 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
10/23/1991 | EP0452873A1 1,8-Naphthyridin-2-one derivatives |
10/23/1991 | EP0452850A1 4-[3-(4-Oxothiazoldinyl)]butynylamines, a process for their preparation and their use as medicaments |
10/23/1991 | EP0452847A2 Use of a hypoallergenic wheat preparation for preparing a processed food for a person afflicted with food allergies to wheat |
10/23/1991 | EP0452809A2 A therapeutic agent for pollakiuria, urinary urgency or incontinence of urine comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives |
10/23/1991 | EP0452765A2 Pharmaceutical composition and medical uses of dioxopiperidine derivatives, especially as immune response potentiators, antiviral and antibacterial agents |
10/23/1991 | EP0452712A1 4-Quinolyl-dihydropyridines, process for their prepatation and their use in medicaments |
10/23/1991 | EP0452697A1 Stabilizer for 4-ethyl-2-hydroxyimino5-nitro-3-hexenamide-containing preparation and stabilizing method therefor |
10/23/1991 | EP0452680A1 Substituted purines, process for their preparation and their use as antiviral agents |
10/23/1991 | EP0452660A2 L-glutamic acid derivatives |
10/23/1991 | EP0452587A1 Dihydroxy sulfonamide and sulfinamide renin inhibitors |
10/23/1991 | EP0452507A1 Medicine comprising tocopheryl glycoside as active ingredient |
10/23/1991 | EP0452390A1 Halo substituted aminotetralins. |
10/23/1991 | EP0452389A1 Liquid sustained release composition |
10/23/1991 | EP0452384A1 Fentanyl containing aerosol compositions. |
10/23/1991 | EP0291507B1 Electronic inclinometer |
10/23/1991 | CN1055537A 3,5-disubstituted-2-isoxazolines, process for their preparation, agents containing them and their use |
10/23/1991 | CN1055485A Stable primycin agueous solution, composition of pharmaceutical and protective skin agent containing same and process for their preparation |
10/23/1991 | CN1014411B Process for preparing n((((1-(6-fluo-2-naphthyl) methyl)-4-piperidyl) amino) carboxyl) pyridylcarboxamide |
10/23/1991 | CN1014410B Process for preparing 7-(3-aryl-1-piperazinyl)-and 7-(3-cyclohexyl-1-piperazinyl)-3 quinolonecarboxylic acids |
10/23/1991 | CN1014409B Manufacturing process for asscorbic acid derivative |
10/23/1991 | CN1014393B Preparing prepn. |
10/22/1991 | US5059714 Inhibitors of lysyl oxidase |
10/22/1991 | US5059712 Isolating aminoarginine and use to block nitric oxide formation in body |
10/22/1991 | US5059699 Water soluble derivatives of taxol |
10/22/1991 | US5059696 Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors |
10/22/1991 | US5059693 Reductive dehalogenation |
10/22/1991 | US5059685 Pretreating natural polysaccharide with acid or alkaline hydroxide, dissolving, suspending in organic solvent, reacting with amine or amino acids, cationization with quaternary ammonium salt |
10/22/1991 | US5059627 For mammals suffering from degenerative nervous system disorders |
10/22/1991 | US5059626 Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
10/22/1991 | US5059624 Guanidine derivatives having hypotensive activity, composition containing them and process for obtaining them |
10/22/1991 | US5059622 Method for reducing blood pressure levels in hypertensive persons |
10/22/1991 | US5059619 Stable freeze-dried polyhematoporphyrin ether/ester |
10/22/1991 | US5059615 Treatment of mycoses |
10/22/1991 | US5059613 Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors |
10/22/1991 | US5059612 Rolipram |
10/22/1991 | US5059611 Anti-inflammatory 5-hydroxy-2-furanones |
10/22/1991 | US5059610 Treatment of hypersensitive disorders; antiinflammatory, antiallergic agents |
10/22/1991 | US5059608 Bicyclic amine compound and a process for the preparation thereof |
10/22/1991 | US5059607 Imidazolyl benzisoquinolines useful as 5-ht3 receptor antagonists |
10/22/1991 | US5059606 Combination of pyrimidine derivatives and calcium antagonists to induce and stimulate hair growth and reduce hair loss |
10/22/1991 | US5059603 Method and composition for treating impotence |
10/22/1991 | US5059602 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
10/22/1991 | US5059601 Imidazolone derivatives with activity on central nervous system and antihypertensive activity, preparation methods thereof, and pharmaceutical compositions containing them |
10/22/1991 | US5059600 Treating habit disorders |
10/22/1991 | US5059599 Derivatives of 1-phenyl 1,4-dihydro 3-amino 4-oxo pyridazines, their preparation and their use in therapy |
10/22/1991 | US5059597 Animal growth regulators; enterobacter |
10/22/1991 | US5059596 Azabicyclo compounds |
10/22/1991 | US5059595 Pharmaceutical compositions containing 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in controlled-release form active in the therapy of organic mental disturbances |
10/22/1991 | US5059594 Phytic acid compositions |
10/22/1991 | US5059592 Composition for prevention and (or) treatment of AIDS |
10/22/1991 | US5059427 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof |
10/22/1991 | US5059424 Applying transparent hydrogel to wound, visibily inspect wound without removing dressing product |
10/22/1991 | US5059422 Continuous release phenylethanolamine derivative compositions |
10/22/1991 | US5059416 Zinc compound delivery system with improved taste and texture |
10/22/1991 | US5059412 Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
10/22/1991 | CA1291293C Substituted 7-oxomitosanes |
10/22/1991 | CA1291165C Alkylsulfonamidophenylalkylamines |
10/22/1991 | CA1291164C Indane sulfonamide antiarrythmic agents |
10/22/1991 | CA1291163C Benzenesulfonamido derivatives |
10/22/1991 | CA1291143C Hmg-coa reductase inhibitors |
10/22/1991 | CA1291138C Alkoxyimino ether derivatives of 5-acyl-2(1h)- pyridinones |
10/22/1991 | CA1291137C 1,4-dihydropyridines with diphenylpiperidylester group |
10/22/1991 | CA1291136C Quinoline derivatives, their preparation and therapeutic compositions containing the same |
10/22/1991 | CA1291135C Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same |
10/22/1991 | CA1291134C Process for preparing 1,5-benzothiazepine derivatives |
10/22/1991 | CA1291133C Optically active 2-chloro-12-(3-dimethylamino-2- methylpropyl)-12h-dibenzo ¬d,g| ¬1,3,6| dioxazocines and a process for the preparation thereof |
10/22/1991 | CA1291131C 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8,-inter- m-phenylene pgi _derivatives |
10/22/1991 | CA1291129C Mono- and diepoxide derivatives of delta__-ll-f28249 compounds |
10/22/1991 | CA1291128C 23-deoxy-27-halo(chloro or bromo) derivatives of ll-f28249 compounds |
10/22/1991 | CA1291125C Pyrimidine derivatives |
10/22/1991 | CA1291122C 3'-hydroxy-4'-epi-amino anthracyclines |
10/22/1991 | CA1291121C 12- and 13-bromoergoline derivatives |
10/22/1991 | CA1291119C 2-substituted ergoline derivatives, processes for their preparation and use thereof as medicinal agents |
10/22/1991 | CA1291117C 2.beta.-MORPHOLINO-ANDROSTANE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION |
10/22/1991 | CA1291054C Antitumor antibiotics (ll-e33288 complex) |
10/22/1991 | CA1291044C Spray dried acetaminophen |
10/22/1991 | CA1291043C Composition and method for reducing acetaldehyde toxicity |
10/22/1991 | CA1291041C Centrally-acting muscle relaxants |
10/22/1991 | CA1291040C Prophylactic and therapeutic agent for hepatic disorder |
10/22/1991 | CA1291039C Transdermal administration of certain azepines |
10/22/1991 | CA1291038C Method for preventing coloration of aqueous preparations of cefmenoxime |
10/22/1991 | CA1291037C Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
10/22/1991 | CA1291036C Nasal administration of drugs |
10/21/1991 | WO1991016333A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
10/21/1991 | WO1991016298A1 Antiinflammatory hydroxamic acids and n-hydroxyureas |
10/21/1991 | CA2080916A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
10/21/1991 | CA2078216A1 Antiinflammatory hydroxamic acids and n-hydroxyureas |
10/21/1991 | CA2040773A1 Naphthalene derivatives |
10/20/1991 | WO1991016052A1 Use of minoxidil for treating erectile impotence |
10/20/1991 | CA2080825A1 Minoxidil for treating erectile impotence |
10/20/1991 | CA2040747A1 Pyridine derivatives |
10/20/1991 | CA2040608A1 Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
10/20/1991 | CA2040107A1 Amine derivatives |
10/19/1991 | WO1991016334A1 Erythromycin derivatives |
10/19/1991 | WO1991016078A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
10/19/1991 | CA2080583A1 Erythromycin derivatives |
10/19/1991 | CA2058985A1 Conjugate compounds containing aza-macrocycles, and processes for their preparation |
10/19/1991 | CA2040680A1 Therapeutic agent for dysuria comprising .alpha.-phenyl-.alpha.-pyridylalkanoic acid derivatives |